Premium
Oxidation of Carbamazepine by Lipopathic Mn(VII), Cetyltrimethylammonium Permanganate: A Mechanistic Study
Author(s) -
Garnayak Sarita,
Patel Sabita
Publication year - 2015
Publication title -
international journal of chemical kinetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.341
H-Index - 68
eISSN - 1097-4601
pISSN - 0538-8066
DOI - 10.1002/kin.20920
Subject(s) - chemistry , permanganate , carbamazepine , reaction mechanism , ionic liquid , ionic bonding , potassium permanganate , kinetics , reaction rate , redox , photochemistry , inorganic chemistry , medicinal chemistry , ion , organic chemistry , catalysis , physics , quantum mechanics , neuroscience , epilepsy , biology
In this contribution, we report the oxidation of an established anticonvulsant and antiepileptic drug, carbamazepine, by a lipopathic oxidant, cetyltrimethylammonium permanganate (CTAP), in a nonpolar medium. 1 H ‐Dibenzo[ b,f ]azepine‐4,5‐dione is found to be the major product of the oxidation reaction. The kinetics of the reaction is studied in organic media spectrophotometrically by monitoring the disappearance of Mn(VII) at 530 nm. The reaction is found to be fractional order with respect to carbamazepine and first order with respect to CTAP. Based on the experimental findings, a suitable ionic mechanism is proposed where carbamazepine reacts with CTAP in a slow rate‐determining step to form a hypomanganate ester intermediate through a nonpolar cyclic transition state. Subsequently, the intermediate decomposes and hydrolyzes in fast steps to the dicarbonyl product. The proposed reaction mechanism is also supported by the effect of solvent and temperature on the rate of the reaction. The addition of ionic surfactants increases the rate of reaction, and the catalyzing effect is explained through the possible formation of mixed reverse micellar aggregates where carbamazepine is partitioned more to the interfacial region in the vicinity of the permanganate anion.